|
NeuTec Pharma PLC.(Other News To Note)(Brief Article)
Publication: BioWorld International Publication Date: 22-OCT-03 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2003 A Thomson Healthcare Company
* NeuTec Pharma PLC, of Manchester, UK, said 20 hospitals in six European countries have agreed to take part in Phase III trials of Aurograb for the treatment of the hospital-acquired infection methicillin-resistant Staphylococcus aureus (MRSA). That follows the completion of two Phase II studies showing the product was...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from BioWorld International |
Trendlines International Ltd. Group.(Other News To Note)(Brief Article...
October 22, 2003
|
Transgene S.A., of Strasbourg, France, entered an agreement with the A...
October 22, 2003
|
TopoTarget Prolifix A/S.(Other News To Note)(Brief Article)
October 22, 2003
|
Switch Biotech AG.(Other News To Note)(Stefan Schulze appointed Chief ...
October 22, 2003
|
Speedel Group.(Other News To Note)(reports on Speedel Experimenta AG p...
October 22, 2003
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
